Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeucaFRA:7HD +1.18%95 EV-to-OCF is 8.96 as of Aug. 26, 2026, which is 23% below its 10-year median of 11.67. GuruFocus rates FRA:7HD with a GF Score™ of 95/100 and a GF Value™ of €196.82. The stock has 5 warning signs investors should review. Among 119 Medical Distribution companies, Neuca ranks worse than 52.1% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Neuca's Enterprise Value is €937 Mil.
Neuca's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €105 Mil. Therefore, Neuca's EV-to-OCF for today is 8.96.
The historical rank and industry rank for Neuca's EV-to-OCF or its related term are showing as below:
FRA:7HD'
s EV-to-OCF Range Over the Past 10 Years
Min: -94.41 Med: 11.67 Max: 71.8
Current: 9.24
During the past 13 years, the highest EV-to-OCF of Neuca was 71.80. The lowest was -94.41. And the median was 11.67.
FRA:7HD's EV-to-OCF is ranked worse than 52.1% of 119
companies
in the Medical Distribution industry
Industry Median: 8.75
vs FRA:7HD: 9.24
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-26), Neuca's stock price is €171.00.
Neuca's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €9.040. Therefore, Neuca's PE Ratio (TTM) for today is 18.92.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Neuca's share price for today is €171.00.
Neuca's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €9.040.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Neuca EV-to-OCF Related Terms
Neuca EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Neuca's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Neuca's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuca EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Neuca's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Neuca's EV-to-OCF falls into.
Neuca's current Enterprise Value is €937 Mil.
Neuca's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €105 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuca (FRA:7HD) has a EV-to-OCF of 8.96 as of Aug. 26, 2026. This is 23% below median its historical median of 11.67. According to the industry distribution chart, Neuca ranks #62 out of 119 companies in the Medical Distribution industry, placing it in the top 52.1%.
Is Neuca's EV-to-OCF too high?
Neuca's current EV-to-OCF of 8.96 is 23% below median its 10-year median of 11.67. The Medical Distribution industry median EV-to-OCF is 8.75. Neuca's value of 8.96 is 2.4% above this industry median. Based on the distribution chart, Neuca ranks #62 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Neuca has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Neuca ranks #62 out of 119 companies for EV-to-OCF. This places Neuca in the lower half of its industry. The industry median EV-to-OCF is 8.75. Neuca's value of 8.96 is 2.4% above this benchmark. While the company's 10-year median is 11.67 vs. the industry median of 8.75, Neuca has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 8.75, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuca's current EV-to-OCF of 8.96 is 2.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 8.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuca's current EV-to-OCF is 8.96, which is 23% below median its own 10-year median of 11.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (FRA:7HD) has a current EV-to-OCF of 8.96. The stock's GF Value™ is €196.82, compared to a current price of €171.00 — trading 13.1% below its estimated fair value. The current EV-to-OCF is 8.96, which is 23% below median its 10-year median of 11.67 and 2.4% above the Medical Distribution industry median of 8.75. Neuca's overall GF Score™ is 95/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Neuca (FRA:7HD), the current EV-to-OCF is 8.96 as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neuca (FRA:7HD) Overvalued in 2026?
Based on GuruFocus' analysis, Neuca stock appears to be undervalued.
The current stock price of €171.00 is trading 13.1% below its estimated GF Value™ of €196.82.
Key valuation signals for FRA:7HD:
EV-to-OCF: 8.96 (23% below median its 10-year median of 11.67)
GF Value™: €196.82 vs. price of €171.00 (13.1% below fair value)
Industry Position: 2.4% above the Medical Distribution median (#62 of 119)
No single metric tells the full story. See the FRA:7HD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
95GF Score
Get the complete analysis for FRA:7HD
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7HD has been successfully added to your 
